LANTERN PHARMA INC. : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

Effective January 12, 2023, Lantern Pharma Inc.'s Board of Directors approved the amendment of the employment agreement, as amended, for Kishor G. Bhatia, Chief Scientific Officer, to increase Dr. Bhatia's annual base salary to $235,000, with such increase to take effect with the first pay period in January 2023.

1

© Edgar Online, source Glimpses